🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

Studying Phenotypes of Gestational Diabetes Mellitus in an Asian Pregnant Cohort

Recruitingn/aAges 21 Years - 45 YearsFemaleNational University Health System, Singapore
NCT06542718 on ClinicalTrials.gov ↗
💬

In plain words

What the trial is, and whether it could suit you

Gestational diabetes mellitus (GDM) is a transient hyperglycemic condition identified during pregnancy in women without a history of chronic diabetes. Evidence indicates that GDM can lead to various adverse health outcomes, including preterm birth, progression to pre-diabetes, and type 2 diabetes after delivery in mothers. Notably, GDM is becoming increasingly prevalent among Asian pregnant women due to rising rates of overweight and obesity, as well as genetic susceptibility. Despite growing recognition of GDM, its treatment efficiency and efficacy remain poor, primarily due to its heterogeneity, which is underpinned by various pathophysiological mechanisms. Therefore, a better understanding of GDM heterogeneity can aid clinicians in providing more targeted treatment and follow-up strategies for GDM mothers. This study aims to define GDM phenotypes based on in vivo cardio-metabolic pro

Sign in to get the eligibility rules as simple questions to take to your doctor.

Sign in
📋 Eligibility rules (as published)
Inclusion Criteria: * Gestational age of ≤ 13 weeks 6 days * Overweight and obese subjects with BMI of 23kg/m² - 24.9kg/m² and ≥ 25.0kg/m², respectively * Aged 21-45 years with singleton pregnancy * Plan to be followed up during the whole pregnancy and deliver at NUH * Chinese, Malay or Indian ethnicity for pregnant subject * Can complete questionnaires in English language * Willing to wear continuous glucose monitoring device at least for 7 days at each required clinic visit Exclusion Criteria: * Participants who are not Singapore citizens or Singapore Permanent Residents, not intending to eventually deliver in Singapore National University Hospital and to reside in Singapore for the next 2 years * Have serious skin conditions (eg. eczema) that precludes wearing the sensor for 14 days * With history of Type 1 diabetes or Type 2 diabetes * With chronic preexisting life-threatening conditions including pancreatic cancer, end-stage kidney dysfunction, and psychosis * Unable to read or speak English
💊

What it tests

  • Not listed
📍

Where

1 site
Department of Obstetrics & Gynaecology
Singapore, Singapore
🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy